Hypertrophic obstructive cardiomyopathy. The Lancet, 2016. ,
Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy, European Heart Journal, vol.9, issue.8, pp.893-898, 1988. ,
DOI : 10.1093/oxfordjournals.eurheartj.a062584
Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy, The Lancet, vol.339, issue.8805, pp.1318-1323, 1992. ,
DOI : 10.1016/0140-6736(92)91961-7
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy, Circulation, vol.85, issue.6, pp.2149-2161, 1992. ,
DOI : 10.1161/01.CIR.85.6.2149
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy, Circulation, vol.90, issue.6, pp.2731-2742, 1994. ,
DOI : 10.1161/01.CIR.90.6.2731
DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience., Heart, vol.75, issue.1, pp.44-49, 1996. ,
DOI : 10.1136/hrt.75.1.44
Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial, Journal of the American College of Cardiology, vol.29, issue.2, pp.435-441, 1997. ,
DOI : 10.1016/S0735-1097(96)00473-1
Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study, European Heart Journal, vol.18, issue.8, 1997. ,
DOI : 10.1093/oxfordjournals.eurheartj.a015435